Team(TISI)
Search documents
Enhanced Fortifies Executive Leadership Team & Board of Directors
Prnewswire· 2025-11-20 00:32
Core Insights - Enhanced has strengthened its executive leadership team and board of directors to drive operational excellence and prepare for the inaugural Enhanced Games scheduled for May 24, 2026 [1][10]. Executive Appointments - Maximilian Martin, Co-Founder, has been appointed as CEO, taking over operational leadership from Founder Dr. Aron D'Souza, who remains a shareholder [2]. - Christian Angermayer has been appointed as Executive Chairman of the board, bringing extensive experience as an entrepreneur and financier with over $7 billion in assets under management [3]. - Jim Murren joins the board, bringing a strong background in leading global entertainment companies, including his tenure as Chairman and CEO of MGM Resorts [4][5]. Financial Leadership - Sid Banthiya has been named Chief Financial Officer, with over two decades of experience in finance and operations, previously holding key roles at Milk Bar and Blue Apron [6]. Brand and Sporting Operations - Alex Lopez has been promoted to Chief Brand Officer, tasked with global brand positioning and go-to-market strategy, leveraging his extensive experience at Nike [7]. - Rick Adams has been appointed Chief Sporting Officer, overseeing events and athlete management, with a distinguished background in high-performance athletic operations [8]. Communications Strategy - Chris Jones has been appointed Chief Communications Officer, responsible for public affairs and investor relations, previously serving at FanDuel and Interpublic Group [9]. Company Vision - The expansion of the leadership team signifies Enhanced's commitment to attracting top talent to build a sustainable business and position the Enhanced Games as an innovator in sports [10]. - Enhanced aims to revolutionize the Performance Medicine category, providing products that optimize health, performance, and recovery for athletes and consumers alike [10][12].
Team's Q3 Earnings Fall Y/Y Despite Strong Revenue Gains
ZACKS· 2025-11-18 13:55
Core Insights - Team, Inc. (TISI) shares have decreased by 6.3% following the third-quarter 2025 results, contrasting with a 1.9% decline in the S&P 500 index, although the stock has increased by 11.4% over the past month, indicating improved investor sentiment [1] Financial Performance - Revenues for the quarter rose by 6.7% year-over-year to $225 million, with gross margin expanding by 8.4% to $58 million, and adjusted EBITDA increasing by 28.6% to $14.5 million, leading to a margin improvement of 110 basis points [2] - The net loss was reported at $11.4 million, slightly higher than the $11.1 million loss from the previous year, with earnings per share reflecting a loss of $2.68 compared to a loss of $2.52 last year [2] Segment Performance - The Inspection & Heat-Treating (IHT) segment generated revenues of $113.8 million, a 5.7% increase, driven by higher service activity in the U.S. and an 8.9% increase in international markets [3] - The Mechanical Services (MS) segment saw revenues improve by 7.8% to $111.2 million, supported by stronger U.S. turnaround activity and better results in Canada, with operating income rising by 31.2% to $5.9 million [3] Cost Management - Adjusted selling, general and administrative expenses decreased to 20.8% of revenues from 21.7% in the prior-year quarter, indicating progress in cost control, although corporate expenses increased due to non-recurring legal fees, compressing consolidated operating income to $1.3 million from $3.2 million [4] Management Commentary - Management noted that adjusted EBITDA reached its highest level for a third quarter since at least 2016, with growth in adjusted EBITDA outpacing revenue gains, reflecting successful cost-reduction and margin-expansion initiatives [5] - The company is focused on maintaining cost discipline, enhancing commercial execution in higher-margin markets, and expanding wallet share among existing customers, with ongoing improvements in margin and cost structure simplification [6] Revenue Drivers - Revenue growth was primarily driven by volume gains in both core segments, with IHT benefiting from increased U.S. activity and international work, while MS saw elevated demand in the U.S. and improved Canadian activity [7] Cost Factors - Margin improvements were attributed to field cost rationalization and a better project mix, although consolidated operating income contracted due to higher non-recurring corporate expenses [8] Guidance - Management expects full-year 2025 revenue growth of approximately 5% and adjusted EBITDA growth of roughly 13%, with anticipated year-over-year gains in the fourth quarter and further improvements in international operations [10] Other Developments - Team completed a $75 million private placement of preferred stock, using proceeds to reduce total debt from $325.1 million to $302.8 million, enhancing liquidity and financial flexibility [11]
TransCode Therapeutics Expands Executive Team with Appointment of Dr. Michel Janicot as Senior Development Officer
Prnewswire· 2025-11-17 13:01
Core Insights - TransCode Therapeutics has appointed Dr. Michel Janicot as Senior Development Officer to enhance its oncology pipeline and drug development efforts [1][3] - Dr. Janicot brings over 35 years of experience in pharmaceutical research and drug development, particularly in oncology [1][2] - The company focuses on innovative RNA-based therapies for advanced malignancies, with lead candidates TTX-MC138 and Seviprotimut-L targeting metastatic and recurrent cancers [1][5] Company Overview - TransCode Therapeutics specializes in immuno-oncology and targeted cancer therapies, aiming to treat advanced malignancies [5] - The lead therapeutic candidate, TTX-MC138, targets metastatic tumors that overexpress microRNA-10b, a known biomarker for metastasis [5] - The company has a portfolio of first-in-class therapeutic candidates designed to activate the immune system against cancer cells [5] Leadership and Expertise - Dr. Janicot has a Ph.D. in Biochemistry and has held senior leadership roles in major pharmaceutical companies, including Janssen Pharmaceutica [1][4] - He has founded a consulting firm and co-founded a nonprofit focused on pediatric oncology drug development, showcasing his commitment to advancing cancer therapies [2][4] - His role at TransCode will involve supporting strategic R&D initiatives and clinical development strategies for investigational oncology programs [3][4]
The Starlab International Space Station Just Added a Big U.S. Defense Contractor to Its Team
The Motley Fool· 2025-11-15 12:07
Core Insights - Starlab is positioned as the leading contender to replace the International Space Station (ISS), which is set for disposal after 2030, with significant international support and a strong coalition of partners [2][10] Company Overview - Starlab is led by Voyager Technologies and includes partners such as Hilton Worldwide, Northrop Grumman, Palantir, MDA Space, Airbus, and Mitsubishi, showcasing a diverse and robust coalition [3][4] - Recently, Leidos joined the Starlab team, bringing extensive experience in civil space and defense integration, which will enhance Starlab's capabilities in assembling and integrating the space station [4] Financial Backing - The coalition supporting Starlab boasts a total market capitalization of approximately $890.9 billion and annual revenue of about $250.5 billion, indicating substantial financial resources [7] - Key partners include: - Voyager Space: Market Cap $1.4 billion, Revenue $158 million - MDA Space: Market Cap $2.1 billion, Revenue $965 million - Hilton Worldwide: Market Cap $63.8 billion, Revenue $4.9 billion - Northrop Grumman: Market Cap $80.3 billion, Revenue $40.9 billion - Mitsubishi Corporation: Market Cap $89.3 billion, Revenue $116.3 billion - Airbus: Market Cap $192.5 billion, Revenue $83.4 billion - Palantir Technologies: Market Cap $461.5 billion, Revenue $3.9 billion [7] Competitive Landscape - Starlab faces competition from other coalitions, including Blue Origin's Orbital Reef, which is financially supported by Jeff Bezos but currently unprofitable [6][8] - Starlab's financial strength and broad coalition make it a strong candidate to secure NASA contracts and complete the next ISS [9][10]
Elauwit Connection's Leadership Team to Attend NMHC OPTECH 2025 in Las Vegas
Newsfile· 2025-11-14 13:00
Core Insights - Elauwit Connection, Inc. is celebrating its publicly-traded debut and is focusing on growth and community engagement as it attends the NMHC OPTECH 2025 Conference in Las Vegas [1][2] Group 1: Company Overview - Elauwit is a national managed services provider specializing in turnkey broadband and property-wide WiFi networks for multifamily and student housing communities [4] - The company emphasizes service quality, reliability, and measurable asset value, enabling property owners to provide continuous connectivity as a modern amenity and a source of recurring net operating income (NOI) growth [4] Group 2: Conference Participation - Elauwit’s leadership team will participate in the NMHC OPTECH Conference & Expo from November 16 to November 18, 2025, at the MGM Grand in Las Vegas [1] - The focus during the conference will be on building relationships, exchanging ideas, and exploring collaborative opportunities to enhance connectivity, resident experience, and property performance [2] Group 3: Leadership Statements - Sebastian Shahvandi, the newly appointed Chief Growth Officer, highlighted the importance of engaging with forward-thinking leaders in the multifamily sector to discuss technology that improves operations and resident satisfaction [3] - Elauwit is inviting attendees to visit their booth for networking opportunities, including a drink cart hosted in collaboration with Cambium Networks [3][4]
Team outlines 13% adjusted EBITDA growth target as balance sheet strengthens through $75M Stellex investment (NYSE:TISI)
Seeking Alpha· 2025-11-13 18:42
Group 1 - The article discusses the importance of enabling Javascript and cookies in browsers to prevent access issues [1] - It highlights that users with ad-blockers may face restrictions when trying to access content [1]
Team, Inc. (TISI) Q3 2025 Earnings Call Prepared Remarks Transcript
Seeking Alpha· 2025-11-13 18:41
PresentationGood morning, and welcome to the Team Inc. Third Quarter Update Call. I would now like to turn the conference over to Nelson Haight, Chief Financial Officer. Please go ahead.Nelson HaightExecutive VP & CFO Thank you, operator. Good morning, everyone, and welcome to Team, Inc.'s discussion of our third quarter 2025 operational and financial results. On the discussion today is Keith Tucker, our Chief Executive Officer; and myself, Nelson Haight, Chief Financial Officer. I want to remind you that m ...
Team(TISI) - 2025 Q3 - Earnings Call Transcript
2025-11-13 17:00
Financial Data and Key Metrics Changes - In Q3 2025, the company reported a revenue growth of nearly 7%, approximately $14 million year-over-year, with gross margin increasing by 8.4% and adjusted EBITDA rising to 28.6%, marking the highest level for a third quarter since at least 2016 [4][5][14] - Adjusted selling, general, and administrative expenses decreased to 20.8% of consolidated revenue from 21.7% in Q3 2024, reflecting ongoing cost discipline [6][13] - For the first nine months of 2025, adjusted EBITDA improved by 12%, about $5 million year-over-year, with adjusted net loss down nearly $7 million compared to the same period in 2024 [14][16] Business Line Data and Key Metrics Changes - The inspection and heat treating (IHT) segment experienced a revenue growth of 5.7%, driven by strong activity in the U.S. and an 8.9% growth in international operations, including Canada [5] - The mechanical services segment saw a revenue increase of 7.8%, or $8 million, led by heightened turnaround demand in the U.S. and improved performance in Canada [5] Market Data and Key Metrics Changes - The company noted multiple quarters of growth in Canadian operations, indicating successful initiatives to enhance commercial and financial performance in that region [5] - The diversified portfolio across multiple industries and geographic footprint is expected to help navigate macroeconomic uncertainties [8] Company Strategy and Development Direction - The company aims to continue executing its strategic vision focused on top-line growth, margin improvement, and cash flow generation [7][12] - A recent $75 million private placement of preferred stock with Stellux Capital Management is expected to strengthen the balance sheet and enhance financial flexibility, supporting ongoing margin improvement initiatives [6][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving approximately 5% revenue growth and 13% adjusted EBITDA growth for the full year 2025, driven by cost control and capital discipline [9][14] - The company anticipates improved free cash flow generation in the fourth quarter, reversing adverse working capital trends [15][16] Other Important Information - The company has increased liquidity to $57.1 million as of September 30, 2025, consisting of unrestricted cash and undrawn availability under credit facilities [12] - The leadership team emphasized the importance of safety culture and continuous improvement as vital to the company's success [18][19] Q&A Session Summary - No specific questions or answers were provided in the content regarding the Q&A session.
Team(TISI) - 2025 Q3 - Quarterly Report
2025-11-12 21:49
Revenue Performance - Total revenues increased by $14.2 million or 6.7% year-over-year, reaching $224.976 million for the three months ended September 30, 2025[134] - IHT revenues rose by $6.2 million or 5.7%, driven by $5.0 million from higher callout and nested activity in the U.S.[134] - MS revenues increased by $8.0 million or 7.8%, largely due to a $7.9 million rise in U.S. turnaround activities[134] - Total revenues increased by $32.7 million or 5.1% year-over-year, reaching $671.7 million in the nine months ended September 30, 2025[140] - IHT segment revenue rose by $30.1 million or 9.4%, driven by a $23.0 million increase in U.S. revenue from large turnaround projects and enhanced testing services[140] Operating Income and Expenses - Operating income decreased by $1.8 million to $1.3 million, with IHT operating income increasing by $1.7 million or 16.9%[135] - MS operating income rose by $1.4 million or 31.2%, while corporate operating loss increased by $4.9 million due to higher non-recurring costs[135] - Operating income decreased by $0.5 million or 6.2% to $7.4 million, with IHT operating income increasing by $8.5 million or 30.9%[141] - MS segment operating income fell by $4.3 million or 22.5%, primarily due to decreased international project activity[141] - Non-core expenses totaled $10.5 million, impacting operating income, which would have been $18.0 million excluding these items[143] Net Loss and Adjusted Metrics - The company reported a net loss of $45.4 million, a 46.2% increase compared to the prior year[140] - Adjusted operating income improved by $8.0 million or 80.7% from the prior year, reaching $18.0 million[143] - Adjusted Net Loss for Q3 2025 was $6,062,000, an improvement from $12,538,000 in Q3 2024, while the nine-month loss decreased from $29,264,000 in 2024 to $21,812,000 in 2025[154] - Consolidated Adjusted EBITDA increased to $14,541,000 in Q3 2025 from $11,311,000 in Q3 2024, and for the nine months, it rose from $39,631,000 in 2024 to $44,322,000 in 2025[157] Cash Flow and Liquidity - Free Cash Flow for Q3 2025 was $1,044,000, down from $3,914,000 in Q3 2024, while the nine-month Free Cash Flow showed a significant decline from $(6,311,000) in 2024 to $(35,277,000) in 2025[167] - As of September 30, 2025, the company had approximately $46.5 million of available borrowing capacity under credit facilities, including $36.5 million under Revolving Credit Loans[164] - Operating activities generated a cash outflow of $(28,122,000) for the nine months ended September 30, 2025, compared to a cash inflow of $1,143,000 in the same period of 2024[167] - Total liquidity as of November 10, 2025, was $73.2 million, including $8.1 million in cash and cash equivalents and $65.1 million of undrawn availability under credit facilities[166] Debt and Interest Expense - Interest expense remained consistent at $11.855 million, with cash interest paid increasing to $9.8 million from $7.1 million year-over-year[137] - Interest expense, net decreased by $0.6 million, attributed to lower interest rates on loans, with cash interest paid totaling $22.6 million in 2025[144] - The company reported a significant increase in interest expense, netting $11,855,000 for Q3 2025, compared to $11,770,000 in Q3 2024, indicating rising costs associated with debt[157] - Total debt and finance obligations decreased to $302.8 million as of September 30, 2025, down from $325.1 million at December 31, 2024, reflecting a $22.3 million reduction primarily due to paydowns on loans[169] Tax Provision - The provision for income tax was $0.9 million on a pre-tax loss of $10.5 million, resulting in an effective tax rate of 9.1%[139] - The provision for income tax was $2.2 million on a pre-tax loss of $43.3 million, resulting in an effective tax rate of 5.0%[147] Foreign Currency and Other Income - Other income increased by $3.3 million, primarily due to favorable foreign currency fluctuations[138] - The effect of foreign exchange rate changes on cash for the nine months ended September 30, 2025, was $0.3 million, compared to a negative $0.3 million in 2024, mainly due to fluctuations in the U.S. Dollar against other currencies[176] Debt Issuance and Refinancing - The company experienced a loss on debt extinguishment of $1.283 million related to the prepayment of the 2025 Second Lien Term Loans[138] - Loss on debt extinguishment amounted to $13.1 million due to refinancing activities, including $7.4 million of noncash unamortized debt issuance costs[145] - The company incurred $11.4 million in debt issuance costs related to refinancing transactions completed as of March 12, 2025[174] Compliance and Accounting Policies - The company maintained compliance with its debt covenants as of September 30, 2025, which is crucial for its financial stability moving forward[165] - There were no material changes to critical accounting policies during the nine months ended September 30, 2025[178] - As a smaller reporting company, the company is not required to provide detailed market risk disclosures[179]
Team(TISI) - 2025 Q3 - Quarterly Results
2025-11-12 21:48
Revenue Performance - Revenue for Q3 2025 reached $225.0 million, an increase of $14.2 million or 6.7% year-over-year[4] - Revenues for the three months ended September 30, 2025, were $224,976,000, an increase of 6.0% compared to $210,758,000 for the same period in 2024[28] - Mechanical Services segment revenue grew by 7.8% or $8.0 million, driven by increased turnaround demand in the U.S.[4] - Inspection and Heat-Treating segment revenue rose by 5.7%, with U.S. revenue up 5.3% and international operations, including Canada, growing by 8.9%[4] - Canadian operations saw a revenue increase of 25% across both segments during Q3 2025[6] - The Industrial and High Technology (IHT) segment generated revenues of $113,778,000 for the three months ended September 30, 2025, up from $107,604,000 in 2024, reflecting a growth of 2.1%[34] - The Maintenance Services (MS) segment reported revenues of $111,198,000 for the three months ended September 30, 2025, an increase of 7.0% from $103,154,000 in the same period last year[34] Profitability and Loss - Adjusted EBITDA increased by 28.6% to $14.5 million, representing 6.5% of consolidated revenue, compared to $11.3 million or 5.4% in Q3 2024[5] - Net loss for Q3 2025 was $11.4 million, compared to a net loss of $11.1 million in Q3 2024[10] - Operating income for the three months ended September 30, 2025, was $1,342,000, a decrease of 57.5% from $3,158,000 in the prior year[28] - Net loss attributable to common shareholders for the three months ended September 30, 2025, was $12,057,000, compared to a net loss of $11,126,000 for the same period in 2024[28] - Adjusted Net Loss for Q3 2025 was $6,062,000 compared to $12,538,000 in Q3 2024, showing a 51.6% improvement year-over-year[41] - The net loss for the nine months ended September 30, 2025, was $45,431,000, compared to $31,084,000 for the same period in 2024, indicating a deterioration of 46.3%[41] Cash Flow and Liquidity - Cash and cash equivalents decreased to $14,812,000 as of September 30, 2025, down from $35,545,000 at the end of 2024[30] - The company reported a net cash used in operating activities of $28,122,000 for the nine months ended September 30, 2025, compared to a net cash provided of $1,143,000 for the same period in 2024[32] - The company had total liquidity of $57.1 million, consisting of $10.6 million in cash and $46.5 million in undrawn credit facilities[19] Debt and Financial Position - Total debt decreased to $302.8 million from $325.1 million as of fiscal year-end 2024, primarily due to preferred stock sale proceeds[21] - The company reported a net debt position that includes both current and long-term debt, less cash and cash equivalents, although specific figures were not disclosed in the provided content[41] Expenses and Cost Management - Adjusted Selling, General and Administrative Expense improved to 20.8% of consolidated revenue, down from 21.7% in the prior year[5] - Selling, general, and administrative expenses for Q3 2025 were $56.7 million, up from $50.4 million in Q3 2024, representing a 4.7% increase[46] - Total non-cash/non-recurring items for the nine months ended September 30, 2025, amounted to $27.2 million, compared to $21.1 million for the same period in 2024, reflecting a 28.9% increase[46] - Professional fees and other costs for the nine months ended September 30, 2025, totaled $6,285,000, compared to $2,915,000 in 2024, an increase of 115.5%[41] - The adjusted SG&A expense for the nine months ended September 30, 2025, was $138.7 million, up from $136.7 million in the same period of 2024[46] Depreciation and Amortization - The total depreciation and amortization for the nine months ended September 30, 2025, was $25,676,000, down from $27,934,000 in the same period of 2024, a decrease of 8.1%[41] - Depreciation and amortization in SG&A expenses for Q3 2025 was $5.5 million, slightly down from $5.6 million in Q3 2024[46] Shareholder Information - The weighted-average number of shares outstanding for basic and diluted earnings per share was 4,499,000 for the three months ended September 30, 2025, compared to 4,422,000 in the prior year[28] - Adjusted Net Loss per common share for Q3 2025 was $(1.48), an improvement from $(2.84) in Q3 2024, reflecting a 47.7% reduction in losses per share[41]